Endpoints News 11. März 2026 Lilly plots GLP-1 pill production boost in China, $500M pledge to South Korea
Endpoints News 11. März 2026 RA Capital, Forbion and Canaan appear to back Harbour's CTLA-4 partner Solstice
Endpoints News 10. März 2026 Study suggests long non-coding RNA has potential as new class of genetic medicine
Endpoints News 10. März 2026 Ascletis touts GLP-1 quarterly dosing data; Mineralys apnea Phase 2 misses
Endpoints News 9. März 2026 AbbVie, Gubra post obesity data; Regeneron obesity drug succeeds in China
Endpoints News 9. März 2026 Xenon gets Phase 3 win with epilepsy drug, setting up FDA approval filing